Suppr超能文献

由约束驱动创新引导的氧杂硫杂环戊烷药物中间体的合成。

Synthesis of an Oxathiolane Drug Substance Intermediate Guided by Constraint-Driven Innovation.

作者信息

Kashinath K, Snead David R, Burns Justina M, Stringham Rodger W, Gupton B Frank, McQuade D Tyler

机构信息

Medicines for All Institute, Virginia Commonwealth University, 737 North Fifth Street, Box 980100, Richmond, Virginia 23298, United States.

出版信息

Org Process Res Dev. 2020 Oct 16;24(10):2266-2270. doi: 10.1021/acs.oprd.0c00145. Epub 2020 May 13.

Abstract

A new route was developed for construction of the oxathiolane intermediate used in the synthesis of lamivudine (3TC) and emtricitabine (FTC). We developed the presented route by constraining ourselves to low-cost, widely available starting materials-we refer to this as supply-centered synthesis. Sulfenyl chloride chemistry was used to construct the framework for the oxathiolane from acyclic precursors. This bond construction choice enabled the use of chloroacetic acid, vinyl acetate, sodium thiosulfate, and water to produce the oxathiolane.

摘要

开发了一种新的路线用于构建合成拉米夫定(3TC)和恩曲他滨(FTC)时所用的氧硫杂环戊烷中间体。我们通过限定使用低成本、广泛可得的起始原料来开发此路线——我们将其称为以供应为中心的合成。亚磺酰氯化学用于从无环前体构建氧硫杂环戊烷的骨架。这种键构建方式使得能够使用氯乙酸、乙酸乙烯酯、硫代硫酸钠和水来制备氧硫杂环戊烷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b0/7574620/833f0819e20b/op0c00145_0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验